miR-17-3P regulates the proliferation and survival of colon cancer cells by targeting Par4

Lu,Debao; Tang,Liang; Zhuang,Yan; Zhao,Peng

doi:10.3892/mmr.2017.7863

miR-17-3P regulates the proliferation and survival of colon cancer cells by targeting Par4

Authors:
- Debao Lu
- Liang Tang
- Yan Zhuang
- Peng Zhao
View Affiliations

Affiliations: Department of General Surgery, Tianjin TEDA Hospital, Tianjin 300457, P.R. China, Department of Colorectal Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300202, P.R. China
Published online on: October 25, 2017 https://doi.org/10.3892/mmr.2017.7863
Pages: 618-623

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a common malignancy worldwide. However, the pathogenesis by which CRC progression occurs remains to be elucidated. The present study investigated the role of miRNA (miR)‑17‑3P in the regulation of CRC cell survival. Firstly, miR‑17‑3P expression was aberrantly upregulated in human CRC tumor tissues compared with controls. Further results demonstrated that the proliferation capacity of human CRC SW480 and LoVo cells was significantly increased by an miR‑17‑3P specific mimic, and was inhibited by miR‑17‑3P silencing. Conversely, the apoptosis of human CRC cells was remarkably decreased by miR‑17‑3P mimic, and enhanced by miR‑17‑3P suppression compared with control. Additionally, it was observed that there was a potential binding site of miR‑17‑3P on the 3'‑untranslated region of Prostate apoptosis responde‑4 (Par4) and miR‑17‑3P may directly target Par4 mRNA. In human CRC cells, an miR‑17‑3P inhibitor significantly upregulated Par 4 expression, however the miR‑17‑3P mimic reduced Par4expression. Furthermore, Par4 expression exhibited an inhibitory effect on the proliferation of CRC cells transfected with miR‑17‑3P mimic, and exhibited a promoting role in the repressed apoptosis by miR‑17‑3P mimic. Inconclusion, the results of the present study demonstrated that miR‑17‑3P is important in CRC cell survival by targeting Par4, indicating a novel finding regarding human CRC progression.

View Figures

View References

1	Haigis KM: Molecular pathogenesis of colorectal cancer. Anticancer Res. 11:609–633. 2014.
2	Fearon ER: Molecular genetics of colorectal cancer. Ann Rev Pathol Mechanisms Dis. 6:479–507. 2011. View Article : Google Scholar
3	Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
4	Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, et al: MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer. 10:1242011. View Article : Google Scholar : PubMed/NCBI
5	Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. MicroRNA Cancer Regulation Springer. 1–20. 2013. View Article : Google Scholar
6	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
7	Luo X, Burwinkel B, Tao S and Brenner H: MicroRNA signatures: Novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev. 20:1272–1286. 2011. View Article : Google Scholar : PubMed/NCBI
8	Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H and Matsumura Y: MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila). 3:1435–1442. 2010. View Article : Google Scholar : PubMed/NCBI
9	Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
10	Olive V, Jiang I and He L: mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol. 42:1348–1354. 2010. View Article : Google Scholar : PubMed/NCBI
11	Hebbar N, Shrestha-Bhattarai T and Rangnekar VM: Cancer-selective apoptosis by tumor suppressor par-4. Adv Exp Med Biol. 818:155–166. 2014. View Article : Google Scholar : PubMed/NCBI
12	Pereira MC, de Bessa-Garcia SA, Burikhanov R, Pavanelli AC, Antunes L, Rangnekar VM and Nagai MA: Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells. Int J Oncol. 43:531–538. 2013. View Article : Google Scholar : PubMed/NCBI
13	Da Bessa-Garcia SA, Pereira M and Nagai MA: Regulation of PAWR expression by estrogen and growth factors in breast cancer cells. Int J Mol Med. 24:2009.
14	Yang K, Shen J, Chen SW, Qin J, Zheng XY and Xie LP: Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells. Oncol Rep. 35:2487–2493. 2016. View Article : Google Scholar : PubMed/NCBI
15	Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B and Ye Q: miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally. FEBS Lett. 588:1913–1920. 2014. View Article : Google Scholar : PubMed/NCBI
16	Du WW, Li X, Li T, Li H, Khorshidi A, Liu F and Yang BB: The microRNA miR-17-3p inhibits mouse cardiac fibroblast senescence by targeting Par4. J Cell Sci. 128:293–304. 2015. View Article : Google Scholar : PubMed/NCBI
17	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
18	Xi Y, Formentini A, Chien M, Weir DB, Russo JJ and Ju J, Kornmann M and Ju J: Prognostic values of microRNAs in colorectal cancer. Biomarker Insights. 2:113–121. 2006.PubMed/NCBI
19	Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol. 34:1069–1075. 2009.PubMed/NCBI
20	Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM and Negrini M: mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer. 6:542007. View Article : Google Scholar : PubMed/NCBI
21	Chen JA, Huang YP, Mazzoni E, Tan GC, Zavadil J and Wichterle H: Mir-17-3p controls spinal neural progenitor patterning by regulating Olig2/Irx3 cross-repressive loop. Neuron. 69:721–735. 2011. View Article : Google Scholar : PubMed/NCBI
22	Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, Lu WY, Xuan JW, Deng Z and Yang BB: Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci. 126:1517–1530. 2013. View Article : Google Scholar : PubMed/NCBI
23	Li H and Yang BB: Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget. 3:1653–1668. 2012. View Article : Google Scholar : PubMed/NCBI
24	Faltejskova P, Bocanek O, Sachlova M, Svoboda M, Kiss I, Vyzula R and Slaby O: Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. Cancer Biomark. 12:199–204. 2012. View Article : Google Scholar : PubMed/NCBI
25	Xie Y and Emergency DO: Application of miRNA-17-3p combined with CEA in the diagnosis and treatment of colorectal cancer. J Clin Med Practice. 2014.
26	Chen X, Sahasrabuddhe AA, Szankasi P, Chung F, Basrur V, Rangnekar VM, Pagano M, Lim MS and Elenitoba-Johnson KS: Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival. Cell Death Differ. 21:1535–1545. 2014. View Article : Google Scholar : PubMed/NCBI
27	Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T and Rangnekar VM: Binding and phosphorylation of par-4 by Akt is essential for cancer cell survival. Mol Cell. 20:33–44. 2005. View Article : Google Scholar : PubMed/NCBI
28	Ranganathan P and Rangnekar VM: Regulation of cancer cell survival by par-4. Ann N Y Acad Sci. 1059:76–85. 2005. View Article : Google Scholar : PubMed/NCBI